marijuana

Medipharm Labs Corp (OTC: MLCPF) has announced that its subsidiary has received a sales license from Health Canada that allows it to start delivering products based on previously established supply agreements. What Happened Medipharm Labs, a Canadian company that specializes in production...

The extreme volatility in shares of Tilray Inc (NASDAQ: TLRY) continued Friday, but it could be a result of the limited supply of available shares, according to Canopy Growth Corp (NYSE: CGC) CEO Bruce Linton. What Happened Tilray's volatility is likely the result of investors and traders...

Tilray Inc. (NASDAQ: TLRY) investors witnessed some extreme volatility this week. Shares of the cannabis company surged as high as 90 percent Wednesday before the stock was halted five times leading up to the closing bell. Characteristics of Tilray’s stock performance this week very...

Canadian cannabis company Tilray Inc (NASDAQ: TLRY) experienced a wild Wednesday trading session, which is clearly not a positive for the relatively investment new sector, according to Steve Ottaway. The Pro Ottaway, managing director at GMP Securities, discussed Tilray and cannabis stocks...

The unbelievable run in Tilray Inc (NASDAQ: TLRY) found a new gear Wednesday when the stock traded up more than 50 percent after the company's Tuesday announcement that it had gained approval from the DEA to import marijuana to the U.S. Another huge day put Tilray stock up a...

Beverage companies aren't usually associated with disruption and innovation, but at least two names deserve credit for their recent M&A deals: PepsiCo, Inc. (NASDAQ: PEP) and Constellation Brands, Inc. (NYSE: STZ), according to CNBC's Jim Cramer. PepsiCo PepsiCo's acquisition of...

Shares of Canopy Growth Corp (NYSE: CGC) skyrocketed higher by more than 50 percent early Wednesday morning in reaction to an expansion of its partnership with the beverage alcohol company Constellation Brands, Inc. (NYSE: STZ). What Happened Canopy and Constellation initially struck a partnership...

The U.S. Marijuana Index, which hit a trough at 72.93 on April 3, has since recovered, with the Canadian Senate's June 19 ratification of the bill to legalize recreational pot serving as a shot in the arm for all marijuana stocks. Prime Minister Justin Trudeau announced Oct. 17 as the official...

MassRoots Inc (OTC: MSRT), a nano-cap provider of an online platform that allows consumers to provide reviews of cannabis strains and products, confirmed in a press release after Tuesday's market close it that filed a lawsuit against former CEO Isaac Dietrich. Chatter that Dietrich was ousted...

The month of August has been hard one for cannabis drug stocks. After Zynerba Pharmaceuticals Inc (NASDAQ: ZYNE) reported a pair of disappointing trial results in its Phase 2 STAR 1 and STOP trials, respectively, the company’s market cap went up in smoke to the tune of a more than 50 percent...

Shares of Zynerba Pharmaceuticals Inc (NASDAQ: ZYNE), plunged 56 percent in pre-market trading after the company announced that its transdermal synthetic cannabinoid treatment for epilepsy, ZYN002, didn’t demonstrate a statistically significant reduction in median seizure frequency. Rating...

Zynerba Pharmaceuticals Inc (NASDAQ: ZYNE) is about to embark upon a journey with unknown destinations, as investors brace for a trio of reads from the company in the third quarter of 2017. Focus: 3 Phase 2 Reads Of ZYN002 Cantor Fitzgerald said in a note released Monday it remains focused on...

Being a one-trick pony can always prove risky. This rationale seems to have dawned on GW Pharmaceuticals PLC- ADR (NASDAQ: GWPH), a biopharmaceutical company specializing in prescription cannabinoid medicine. Risk Mitigation Through Diversification The company announced Tuesday positive top...

It’s been a hot year for the marijuana industry. Eight states expanded legalization measures on Election Day, bringing the total number of states where marijuana is legal for either medicinal or recreational purposes to 29. Coinciding with that is the big rally in marijuana stocks, which one...

Cannabinoid drug developer GW Pharmaceuticals PLC- ADR (NASDAQ: GWPH) is ending an eventful 2016 on a high note. Shares were surging higher by 6.6 percent on Monday following new drug data out over the weekend and a strong fiscal Q4 earnings report out Monday. Over the weekend, the company reported...